NCT02103023View on ClinicalTrials.gov

Intradermal Influenza Vaccine in the Young

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Influenza Viral Infections
Interventions
DRUG

Imiquimod ointment

5% 250mg imiquimod ointment

DRUG

Aqueous cream

aqueous cream

BIOLOGICAL

Intradermal influenza vaccine

intradermal trivalent influenza vaccine (Intanza15)

BIOLOGICAL

Intramuscular influenza vaccine

intramuscular trivalent influenza vaccine (Vaxigrip)

Trial Locations (1)

Unknown

The University of Hong Kong, Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02103023 - Intradermal Influenza Vaccine in the Young | Biotech Hunter | Biotech Hunter